Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allyson C Banville

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Cell|April 12, 2022
Breaching B cell tolerance in the tumor microenvironmentAllyson C Banville, Brad H Nelson
Nature Reviews. Cancer|April 8, 2022
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunitiesCéline M Laumont, Allyson C Banville, Mara Gilardi, et al.
Gynecologic Oncology|December 21, 2020
Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancerAllyson C Banville, Maartje C A Wouters, Ann L Oberg, et al.
Frontiers in Oncology|January 8, 2024
A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinomaJulyanne Brassard, Michael R Hughes, Pamela Dean, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Cell|April 12, 2022
Breaching B cell tolerance in the tumor microenvironmentAllyson C Banville, Brad H Nelson
Nature Reviews. Cancer|April 8, 2022
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunitiesCéline M Laumont, Allyson C Banville, Mara Gilardi, et al.
Gynecologic Oncology|December 21, 2020
Co-expression patterns of chimeric antigen receptor (CAR)-T cell target antigens in primary and recurrent ovarian cancerAllyson C Banville, Maartje C A Wouters, Ann L Oberg, et al.
Frontiers in Oncology|January 8, 2024
A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinomaJulyanne Brassard, Michael R Hughes, Pamela Dean, et al.
Pageof 1